Join
Live feed
·
INSIDERFilingvia Quantisnow
Rhythm Pharmaceuticals Inc. logo

EVP, Head of International Mazabraud Yann exercised 46,625 shares at a strike of $6.80 and sold $6,620,575 worth of shares (57,000 units at $116.15) as part of a pre-agreed trading plan, decreasing direct ownership by 16% to 55,655 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RYTM (Rhythm Pharmaceuticals Inc.) and more on Quantisnow.